Nelarabine 5 mg/mL
Nelarabine · INJECTION · Zydus Pharmaceuticals USA Inc.
Nelarabine is an intravenous injection used to treat certain types of leukemia and lymphoma. It works by interfering with how cancer cells produce and use nucleosides, which are building blocks needed for cancer cells to grow and divide.
Key Facts
- Brand Name
- Nelarabine
- Generic Name
- Nelarabine
- NDC Code (Product)
70710-1839- Manufacturer
- Zydus Pharmaceuticals USA Inc.
- Strength
- 5 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA215037
- Drug Class
- Nucleoside Metabolic Inhibitor [EPC]
- Marketing Start
- 06/24/2022
Recall History
Zydus Pharmaceuticals (USA) Inc
Failed Impurities/Degradation Specifications
GlaxoSmithKline, LLC.
Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.
Zydus Pharmaceuticals (USA) Inc
Failed Impurities/Degradation Specifications
Frequently Asked Questions
What is Nelarabine used for?
Nelarabine is an intravenous injection used to treat certain types of leukemia and lymphoma. It works by interfering with how cancer cells produce and use nucleosides, which are building blocks needed for cancer cells to grow and divide.
Is Nelarabine a controlled substance?
Nelarabine is not classified as a controlled substance by the DEA.
What is the generic name for Nelarabine?
The generic name for Nelarabine is Nelarabine. There are 5 other brand versions of Nelarabine.
What is the NDC code for Nelarabine 5 mg/mL?
The NDC (National Drug Code) for Nelarabine 5 mg/mL is 70710-1839, listed by Zydus Pharmaceuticals USA Inc..